Jagpreet Chhatwal, Associate Professor at Harvard, Director at Mass General Hospital, Co-founder of Value Analytics Labs, shares new findings with Jérémy Bellaiche, Founder at Shuf about the impact of multi-cancer testing:
“When annual Multi-Cancer Early Detection testing was added on top of the usual diagnostic pathways, the number of stage four cancers dropped by roughly 45% over ten years. That’s a huge shift!
Jagpreet Chhatwal and Jérémy Bellaiche collaborate to raise awareness about it on Shuf.
Link of the episode.”
Other articles about Stage IV Cancer on OncoDaily.